Biogen Deepens U.S. Manufacturing Footprint to Advance Cutting-Edge Therapies

Biogen’s continued investment in North Carolina has created a hub for biotech innovation and economic opportunity.

For over 30 years, Biogen has helped develop North Carolina’s Research Triangle Park (RTP) into a hub for biotech innovation. Biogen’s $2 billion manufacturing investment in the RTP region will modernize and broaden their manufacturing capabilities across multiple functions while integrating advanced automation and artificial intelligence to improve efficiency and quality.

Biogen’s investment builds on the company’s deep roots in North Carolina, where it is the state’s largest biotechnology employer with more than 1,500 manufacturing and technical employees, along with over 400 skilled contractors. Biogen’s long-standing presence in the RTP has fostered a vibrant ecosystem that supports the development of high-skilled workers across many generations.

By continuing to strengthen U.S.-based manufacturing capacity and resilience in the RTP, Biogen is committed to developing transformative treatments to change patients’ lives while contributing to North Carolina’s growing innovation ecosystem and skilled workforce.

Our Work in Action

To maintain America’s global leadership, we need to support the next generation of innovation in medicine.

View All Case Studies

A worker wearing a hard hat, safety glasses, and a reflective vest uses a laptop outdoors at an industrial site with machinery and smoke in the background.

Investing in America’s Biopharmaceutical Infrastructure Strengthens the Economy and Supports Union Workers

Read how the biopharmaceutical industry is growing America’s manufacturing and R&D capabilities to develop the next generation of treatments.

Read case study

Lilly Invests in Virginia to Expand U.S. Manufacturing and Advance Next-Generation Medicines

Lilly’s new state-of-the-art facility in Goochland County will strengthen America’s biopharmaceutical manufacturing capabilities and create economic opportunities for workers and communities across the state.

Read case study

North Carolina’s Research Triangle Park is a Powerhouse for Biopharma Innovation and Economic Growth

Decades of investment in North Carolina’s biopharmaceutical industry has spurred the state’s economy, workforce development and community engagement.

Read case study

A group of people stands in front of a modern office building at a construction site, posing behind a row of shovels and white hard hats on a mound of dirt, with Gilead logos visible on the signs in front.

Gilead Boosts U.S. Manufacturing Capacity to Advance Next-Generation Biologics

Gilead’s new Bay Area facility is supporting the American workforce while underscoring its commitment to strengthening U.S. biopharmaceutical leadership.

Read case study

A large modern industrial building with a white roof, red accents, and glass windows is surrounded by parked cars, trees, and landscaping. The setting appears to be a business or manufacturing facility.

Astellas Strengthens Manufacturing in America to Fuel Gene Therapy Innovation

Astellas opened a state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina, advancing innovation for rare diseases with no or minimal treatment options and strengthening the world-leading U.S. biopharmaceutical manufacturing ecosystem.

Read case study

A modern building with "RayzeBio" signage, large windows, a blue accent, landscaped grounds, and an American flag flying on a flagpole in front.

Bristol Myers Squibb Expands U.S. Manufacturing Presence to Advance Cancer Innovation

Bristol Myers Squibb opened a first-of-its-kind radiopharmaceutical manufacturing facility in Indianapolis, Indiana, bringing significant investment and high-skilled job opportunities to the region.

Read case study